Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy
BackgroundPharmaco-invasive therapy (PIT), combining thrombolysis and percutaneous coronary intervention, was a potential complement for primary percutaneous coronary intervention (pPCI), while bleeding risk was still a concern.ObjectivesThis study aims to compare the efficacy and safety outcomes of...
Main Authors: | Kaiyin Li, Bin Zhang, Bo Zheng, Yan Zhang, Yong Huo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.813325/full |
Similar Items
-
Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
by: Rozita Jalalian, et al.
Published: (2023-04-01) -
Factors Contributing to Delayed Presentation In ST-Elevation Myocardial Infarction and Implication for In-Patient Outcomes
by: S. K. G. P. H. K. Sooriyagoda, et al.
Published: (2024-04-01) -
Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction
by: M. G. Glezer, et al.
Published: (2019-04-01) -
Association of Fibrinogen Level and Index of Microcirculatory Resistance In Acute ST-Segment Elevation Myocardial Infarction Patient Undergoing Primary Percutaneus Coronary Intervention
by: Jusup Endang, et al.
Published: (2015-11-01) -
The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China
by: Qing Lu, et al.
Published: (2021-03-01)